Do All Drug Products Need a Nitrosamine Risk Assessment? FDA’s Risk-Based Approach Explained
Assessing the chemical safety of human drug products requires a thorough understanding of potential mutagenic and carcinogenic impurities that fall […]
Assessing the chemical safety of human drug products requires a thorough understanding of potential mutagenic and carcinogenic impurities that fall […]
Introduction: When a nitrosamine exceeds the acceptable intake limit in a drug product or active pharmaceutical ingredient (API), it triggers
Maintaining a predictable Nitrosamine Testing Timeline has become a critical operational requirement for pharmaceutical manufacturers working to meet stringent compliance
How Long Does Nitrosamine Testing Take? Realistic Timelines by Study Type Read More »
Introduction: Why Conventional Analytical Methods Are Insufficient for Nitrosamines For pharmaceutical manufacturers facing increasing regulatory scrutiny regarding genotoxic impurities, conventional
Introduction: Nitrosamine impurities are among the most scrutinized safety concerns in modern pharmaceutical development, and no NDA or BLA submission
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions Read More »
Introduction: Why a Single Nitrosamine Testing Panel Is Insufficient for Cardiac Drug Classes Understanding drug-class-specific nitrosamine chemistry is one of
Introduction: Pharmaceutical manufacturers function under rigorous oversight from major global regulatory agencies, including the United States Food and Drug Administration
Outsourcing Nitrosamine Testing to a CRO: Scope of Work, Timeline, and Cost Expectations Read More »
Introduction: The Expanding Regulatory Landscape for Nitrosamine Impurities in Biologics The nitrosamine crisis that affected the small-molecule pharmaceutical industry between
Introduction: Why Nitrosamines in Transdermal Patches and Topical Formulations Require Specialized Attention Over the past several years, the pharmaceutical and
Introduction: Nitrosamine Testing Inhalation Drug Products MDI DPI Nasal Spray has become a critical focus area for pharmaceutical manufacturers after
Nitrosamine Testing for Inhalation Drug Products: MDIs, DPIs, and Nasal Sprays Read More »